Ipratropium Bromide (Atrovent) Overview

Flashcards summarizing key concepts and definitions related to ipratropium bromide (Atrovent) used in the paramedic program.

Ipratropium Bromide

A medication classified as an anti-cholinergic and bronchodilator used in the treatment of bronchospasm.

Trade Name

Atrovent, the commercial name under which ipratropium bromide is sold.

Classification

Refers to the drug being categorized as an anti-cholinergic and bronchodilator.

Indications

Conditions treated with ipratropium bromide include bronchospasm in asthma, anaphylaxis, bronchitis, and emphysema.

Pharmacodynamics

Study of the effects of ipratropium bromide on the body, including its actions on muscarinic receptors and bronchodilation.

Bronchodilation Action

The local effect achieved by ipratropium bromide, blocking acetylcholine's effect on bronchial smooth muscles.

Dosage for Adults

500 mcg via nebulizer, repeat prn every 5 minutes, with a maximum total dose of 1500 mcg; for MDI, 1 puff every 30 seconds to a maximum of 15 doses.

Contraindications

Conditions that prevent the use of ipratropium bromide, including hypersensitivity to the drug or atropine.

Precautions

Cautions to take when administering ipratropium bromide, such as in pregnancy, glaucoma, and bladder neck obstruction.

Side Effects

Possible adverse effects of ipratropium bromide include temporary blurred vision, pupil dilation, and dry mouth.

Additive Effects

The combined beneficial effects of ipratropium bromide and beta2-adrenergic agonists due to their different mechanisms for bronchodilation.